Schizophrenia



Study on Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia


Condition:   Schizophrenia
Intervention:   Behavioral: Yoga arm
Sponsors:   National Institute of Mental Health and Neuro Sciences, India;   SCARF (Schizophrenia Research Foundation ,India) Schizophrenia
Recruiting


Add-on Methotrexate for the Treatment of Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: Methotrexate;   Other: Placebo Arm
Sponsor:   Sheba Medical Center
Not yet recruiting


A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: ASP6981;   Drug: Placebo
Sponsor:   Astellas Pharma Global Development, Inc.
Not yet recruiting


A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia


Condition:   Schizophrenia
Interventions:   Combination Product: Aripiprazole Lauroxil;   Drug: Paliperidone Palmitate
Sponsor:   Alkermes, Inc.
Recruiting


Esomeprazole for the Treatment of Negative Symptoms of Schizophrenia


Condition:   Schizophrenia
Intervention:   Drug: esomeprazole
Sponsors:   National Taiwan University Hospital;   National Taiwan University
Completed


Mindfulness and Cognition in Schizophrenia


Condition:   Schizophrenia
Intervention:   Behavioral: Mindfulness
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Fondation de l'Avenir
Not yet recruiting


Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study


Condition:   Acute Schizophrenia Episode
Intervention:   Drug: Aripiprazole
Sponsor:   Peking University
Not yet recruiting


Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia


Condition:   Schizophrenia
Intervention:   Other: Movement group
Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
Completed


Peer-led Psycho-education for Schizophrenia


Condition:   Schizophrenia
Interventions:   Behavioral: Peer-led psycho-education group;   Behavioral: Profession-led psycho-education group;   Other: Routine psychiatric care
Sponsors:   The Hong Kong Polytechnic University;   Hospital Authority, Hong Kong;   Jilin Medical College, China;   Taipei Medical University
Active, not recruiting


Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia


Condition:   Schizophrenia
Intervention:   Drug: Brexpiprazole
Sponsors:   Otsuka Pharmaceutical Development & Commercialization, Inc.;   H. Lundbeck A/S
Recruiting


Trial to Evaluate the Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: Brexpiprazole (OPC-34712);   Drug: Aripiprazole;   Drug: Placebo
Sponsors:   Otsuka Pharmaceutical Development & Commercialization, Inc.;   H. Lundbeck A/S
Recruiting


Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: Aripiprazole IM Depot;   Drug: Aripiprazole tablet
Sponsor:   Otsuka Beijing Research Institute
Recruiting


Evaluation of Stroop Effect in Patients With Schizophrenia


Condition:   Schizophrenia
Intervention:   Behavioral: Modified Stroop effect
Sponsors:   University Hospital, Clermont-Ferrand;   Université d'Auvergne
Recruiting


Evaluation of a Visual Remediation Intervention for Schizophrenia


Condition:   Schizophrenia
Intervention:   Behavioral: Visual Training
Sponsors:   Rutgers, The State University of New Jersey;   University of California, Riverside;   Nathan Kline Institute for Psychiatric Research
Recruiting


Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: Levetiracetam;   Drug: Placebo
Sponsor:   VA Office of Research and Development
Not yet recruiting


An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia


Condition:   Schizophrenia
Intervention:   Drug: SEP-363856
Sponsor:   Sunovion
Recruiting


A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: SEP-363856;   Drug: Placebo - Cap
Sponsor:   Sunovion
Recruiting


A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: ASP4345;   Drug: Matching Placebo
Sponsor:   Astellas Pharma Global Development, Inc.
Completed


Aerobic Exercise for Cognition in Schizophrenia


Condition:   Schizophrenia
Interventions:   Behavioral: Aerobic Exercise;   Behavioral: Balance and Stretching
Sponsors:   VA Office of Research and Development;   Emory University
Recruiting


Nicotinic Receptors and Schizophrenia


Condition:   Schizophrenia
Interventions:   Drug: Risperidone plus Placebo;   Drug: Risperidone plus DMXB-A
Sponsors:   VA Office of Research and Development;   University of Colorado, Denver
Withdrawn


Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels


Condition:   Schizophrenia
Interventions:   Behavioral: Cognitive Remediation Therapy;   Behavioral: Psychoeducation
Sponsors:   Hospital Clinic of Barcelona;   University of Barcelona
Completed


A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia


Condition:   Schizophrenia
Intervention:   Drug: Aripiprazole
Sponsor:   Otsuka Pharmaceutical Co., Ltd.
Completed


Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive


Condition:   Schizophrenia
Interventions:   Other: Gluten Free Flour;   Other: Wheat Flour
Sponsor:   University of Maryland
Completed


A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients


Condition:   Schizophrenia
Interventions:   Drug: AQW051;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed


Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry


Condition:   Schizophrenia
Intervention:   Other: insight variation measure
Sponsor:   Centre Hospitalier Esquirol
Completed

Refine Your Search Advanced Search